Multicenter Retrospective Study of Adjuvant Therapy for Patients with Pathologically Lymph Node-Positive Oral Squamous Cell Carcinoma: Analysis of Covariance Using Propensity Score

Background The presence of pathologically positive lymph nodes (pN+) is a well-known prognostic factor in oral squamous cell carcinoma (OSCC). The aims of this retrospective multicenter study were to assess the prognosis of OSCC patients with pN+ disease; to compare the prognosis of patients with pN...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of surgical oncology 2015-12, Vol.22 (Suppl 3), p.992-999
Hauptverfasser: Yanamoto, Souichi, Otsuru, Mitsunobu, Ota, Yoshihide, Okura, Masaya, Aikawa, Tomonao, Kurita, Hiroshi, Kamata, Takahiro, Kirita, Tadaaki, Yamakawa, Nobuhiro, Ueda, Michihiro, Yamashita, Tetsuro, Komori, Takahide, Shigeta, Takashi, Yokoo, Satoshi, Ogawa, Masaru, Umeda, Masahiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background The presence of pathologically positive lymph nodes (pN+) is a well-known prognostic factor in oral squamous cell carcinoma (OSCC). The aims of this retrospective multicenter study were to assess the prognosis of OSCC patients with pN+ disease; to compare the prognosis of patients with pN+ disease who underwent surgery plus radiotherapy (RT) or concurrent chemoradiotherapy (CCRT) with that of patients who underwent surgery only; and to account for biases associated with treatment selection of adjuvant RT or CCRT. Methods The records of 313 OSCC patients with pN+ disease were retrospectively reviewed. The main outcome measures were 5-year disease-specific survival (DSS) and overall survival (OS) rates. To reduce selection biases associated with retrospective data, the treatment groups were evaluated by Cox proportional hazard analysis with propensity score as a covariate. Results The 5-year OS and DSS survival rates for the entire patient cohort were 51.8 and 59.2 %, respectively. T3–4 stage, closed (
ISSN:1068-9265
1534-4681
DOI:10.1245/s10434-015-4824-5